Skip to main content

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Appoints Veteran Sales Executive as CRO

Brain Scientific (OTCQB: BRSF), a Florida-based medical device technology company, today announced that Daniel Cloutier will serve as its chief revenue officer (“CRO”) in a move designed to propel the company forward on its mission to revolutionize the medical industry. Cloutier brings extensive knowledge and experience in sales strategy and global distribution. His successful track record includes founding LOK Corporation in 2011 after representing CAS Medical System (“CASMED”) as international sales director for eight years and launching the FORE-SIGHT cerebral oximetry internationally. “Daniel’s decades of leadership are crucial at this juncture for Brain Scientific to continue accelerating its path to revenue,” said Hassan Kotob, chairman and CEO of Brain Scientific. “With a growing number of opportunities and partners, Brain Scientific is poised for rapid growth in the immediate future.”

To view the full press release, visit https://ibn.fm/4Qhyp

About Brain Scientific Inc.

Brain Scientific is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific’s corporate strategy, products or investor relations, please visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.